Payment overview · 2025
General Payments
$370.33
3 reported records · 2 companies
Healthcare provider profile · identity verified
Amanda Simionie, ARNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · PORT ST LUCIE, FL · NPI 1831536978
Verified facts
What the public records show
CMS Open Payments records show Amanda Simionie, ARNP received $370.33 in general payments during 2025 across 3 reported records.
AstraZeneca Pharmaceuticals LP accounted for 62.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $230.77 | 62.3% | 2 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $139.56 | 37.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $370.33 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $139.56 | 1 | 2025 |
Source payment records
|
|||||
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $118.39 | 1 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $112.38 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
25 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1475 | 823 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1164 | 610 |
| Amlodipine Besylate | Amlodipine Besylate | 1040 | 596 |
| Losartan Potassium | Losartan Potassium | 766 | 449 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 735 | 422 |
| Lisinopril | Lisinopril | 724 | 402 |
| Omeprazole | Omeprazole | 564 | 309 |
| Metformin Hcl | Metformin Hcl | 515 | 278 |
| Metoprolol Succinate | Metoprolol Succinate | 475 | 266 |
| Simvastatin | Simvastatin | 428 | 230 |
| Alprazolam | Alprazolam | 409 | 255 |
| Hydrochlorothiazide | Hydrochlorothiazide | 364 | 214 |
| Zolpidem Tartrate | Zolpidem Tartrate | 362 | 201 |
| Trazodone Hcl | Trazodone Hcl | 342 | 187 |
| Pantoprazole Sodium | Pantoprazole Sodium | 336 | 216 |
| Gabapentin | Gabapentin | 332 | 189 |
| Pravastatin Sodium | Pravastatin Sodium | 294 | 156 |
| Tamsulosin Hcl | Tamsulosin Hcl | 273 | 158 |
| Metoprolol Tartrate | Metoprolol Tartrate | 266 | 141 |
| Escitalopram Oxalate | Escitalopram Oxalate | 260 | 143 |
| Allopurinol | Allopurinol | 223 | 126 |
| Sertraline Hcl | Sertraline Hcl | 221 | 125 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 214 | 105 |
| Furosemide | Furosemide | 211 | 130 |
| Montelukast Sodium | Montelukast Sodium | 208 | 111 |
| Ezetimibe | Ezetimibe | 199 | 105 |
| Clopidogrel | Clopidogrel Bisulfate | 190 | 105 |
| Potassium Chloride | Potassium Chloride | 181 | 102 |
| Fluticasone Propionate | Fluticasone Propionate | 172 | 103 |
| Atenolol | Atenolol | 168 | 92 |
| Famotidine | Famotidine | 160 | 83 |
| Metformin Hcl Er | Metformin Hcl | 160 | 84 |
| Clonazepam | Clonazepam | 146 | 72 |
| Eliquis | Apixaban | 144 | 70 |
| Meloxicam | Meloxicam | 144 | 93 |
| Duloxetine Hcl | Duloxetine Hcl | 143 | 78 |
| Lorazepam | Lorazepam | 142 | 85 |
| Citalopram Hbr | Citalopram Hydrobromide | 135 | 74 |
| Carvedilol | Carvedilol | 134 | 72 |
| Ozempic | Semaglutide | 133 | 69 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 122 | 62 |
| Temazepam | Temazepam | 118 | 58 |
| Finasteride | Finasteride | 109 | 55 |
| Fluoxetine Hcl | Fluoxetine Hcl | 106 | 58 |
| Valsartan | Valsartan | 103 | 53 |
| Synthroid | Levothyroxine Sodium | 99 | 55 |
| Glimepiride | Glimepiride | 93 | 53 |
| Glipizide | Glipizide | 91 | 53 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 90 | 58 |
| Bupropion Xl | Bupropion Hcl | 87 | 45 |
| Alendronate Sodium | Alendronate Sodium | 86 | 49 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 86 | 50 |
| Valacyclovir | Valacyclovir Hcl | 86 | 47 |
| Tizanidine Hcl | Tizanidine Hcl | 85 | 44 |
| Tramadol Hcl | Tramadol Hcl | 84 | 51 |
| Diazepam | Diazepam | 82 | 57 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 82 | 45 |
| Buspirone Hcl | Buspirone Hcl | 81 | 54 |
| Lovastatin | Lovastatin | 79 | 40 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 79 | 45 |
| Doxazosin Mesylate | Doxazosin Mesylate | 74 | 36 |
| Fenofibrate | Fenofibrate | 74 | 36 |
| Xarelto | Rivaroxaban | 73 | 35 |
| Hydralazine Hcl | Hydralazine Hcl | 71 | 34 |
| Diclofenac Sodium | Diclofenac Sodium | 63 | 32 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 55 | 29 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 55 | 29 |
| Quetiapine Fumarate | Quetiapine Fumarate | 55 | 24 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 54 | 31 |
| Celecoxib | Celecoxib | 54 | 36 |
| Clonidine Hcl | Clonidine Hcl | 54 | 29 |
| Fenofibrate | Fenofibrate Nanocrystallized | 54 | 33 |
| Paroxetine Hcl | Paroxetine Hcl | 54 | 35 |
| Pregabalin | Pregabalin | 54 | 37 |
| Nifedipine Er | Nifedipine | 53 | 30 |
| Benazepril Hcl | Benazepril Hcl | 52 | 26 |
| Januvia | Sitagliptin Phosphate | 51 | 26 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 51 | 50 |
| Ondansetron Hcl | Ondansetron Hcl | 50 | 26 |
| Amitriptyline Hcl | Amitriptyline Hcl | 49 | 27 |
| Warfarin Sodium | Warfarin Sodium | 49 | 20 |
| Donepezil Hcl | Donepezil Hcl | 48 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 48 | 22 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 47 | 30 |
| Irbesartan | Irbesartan | 45 | 24 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 45 | 20 |
| Trulicity | Dulaglutide | 45 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 44 | 21 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 44 | 27 |
| Ramipril | Ramipril | 44 | 25 |
| Verapamil Er | Verapamil Hcl | 44 | 24 |
| Azelastine Hcl | Azelastine Hcl | 43 | 19 |
| Estradiol | Estradiol | 43 | 30 |
| Spironolactone | Spironolactone | 43 | 26 |
| Mirtazapine | Mirtazapine | 42 | 24 |
| Ropinirole Hcl | Ropinirole Hcl | 41 | 23 |
| Cephalexin | Cephalexin | 40 | 40 |
| Glipizide Er | Glipizide | 40 | 28 |
| Meclizine Hcl | Meclizine Hcl | 40 | 35 |
| Mounjaro | Tirzepatide | 40 | 22 |
| Azithromycin | Azithromycin | 39 | 38 |
| Ibuprofen | Ibuprofen | 39 | 24 |
| Sumatriptan Succinate | Sumatriptan Succinate | 39 | 20 |
| Propranolol Hcl | Propranolol Hcl | 37 | 24 |
| Breo Ellipta | Fluticasone/Vilanterol | 36 | 19 |
| Ventolin Hfa | Albuterol Sulfate | 36 | 24 |
| Jardiance | Empagliflozin | 35 | 18 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 35 | 17 |
| Dicyclomine Hcl | Dicyclomine Hcl | 34 | 23 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 34 | 20 |
| Sildenafil Citrate | Sildenafil Citrate | 34 | 17 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 34 | 20 |
| Telmisartan | Telmisartan | 33 | 19 |
| Ipratropium Bromide | Ipratropium Bromide | 31 | 18 |
| Propranolol Hcl Er | Propranolol Hcl | 31 | 16 |
| Enalapril Maleate | Enalapril Maleate | 30 | 15 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 29 | 12 |
| Ondansetron Odt | Ondansetron | 28 | 17 |
| Topiramate | Topiramate | 28 | 14 |
| Eszopiclone | Eszopiclone | 27 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 27 | 16 |
| Prednisone | Prednisone | 27 | 20 |
| Amoxicillin | Amoxicillin | 26 | 19 |
| Doxepin Hcl | Doxepin Hcl | 26 | 11 |
| Liothyronine Sodium | Liothyronine Sodium | 26 | suppressed |
| Naproxen | Naproxen | 26 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 26 | 21 |
| Acyclovir | Acyclovir | 25 | 18 |
| Farxiga | Dapagliflozin Propanediol | 25 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 25 | 15 |
| Lansoprazole | Lansoprazole | 24 | 12 |
| Chlorthalidone | Chlorthalidone | 23 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 23 | 14 |
| Labetalol Hcl | Labetalol Hcl | 23 | 12 |
| Nystatin | Nystatin | 23 | 19 |
| Solifenacin Succinate | Solifenacin Succinate | 23 | suppressed |
| Baclofen | Baclofen | 22 | 15 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 22 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 21 |
| Clobetasol Propionate | Clobetasol Propionate | 21 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 21 | 16 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 21 | 11 |
| Folic Acid | Folic Acid | 21 | suppressed |
| Gemfibrozil | Gemfibrozil | 21 | suppressed |
| Lidocaine | Lidocaine | 21 | 11 |
| Methylprednisolone | Methylprednisolone | 21 | 20 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 21 | 14 |
| Nebivolol Hcl | Nebivolol Hcl | 21 | 11 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 20 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 20 | 12 |
| Candesartan Cilexetil | Candesartan Cilexetil | 20 | suppressed |
| Hydrocortisone | Hydrocortisone | 20 | 12 |
| Vascepa | Icosapent Ethyl | 20 | suppressed |
| Ketoconazole | Ketoconazole | 19 | 14 |
| Mupirocin | Mupirocin | 19 | 14 |
| Myrbetriq | Mirabegron | 19 | 15 |
| Bumetanide | Bumetanide | 18 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 18 | 12 |
| Ibandronate Sodium | Ibandronate Sodium | 17 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 17 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 17 | 13 |
| Anastrozole | Anastrozole | 16 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 16 | suppressed |
| Jantoven | Warfarin Sodium | 16 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 16 | suppressed |
| Lactulose | Lactulose | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | 12 |
| Nortriptyline Hcl | Nortriptyline Hcl | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | 15 |
| Latanoprost | Latanoprost | 15 | suppressed |
| Linzess | Linaclotide | 15 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 15 | suppressed |
| Primidone | Primidone | 15 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 13 | suppressed |
| Levetiracetam | Levetiracetam | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | 13 |
| Rizatriptan | Rizatriptan Benzoate | 13 | suppressed |
| Carisoprodol | Carisoprodol | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | 12 |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 12 | suppressed |
| Memantine Hcl | Memantine Hcl | 12 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 12 | 12 |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 11 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Digoxin | Digoxin | 11 | suppressed |
| Levemir Flexpen | Insulin Detemir | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $370.33 · 3 records | AstraZeneca Pharmaceuticals LP | AIRSUPRA, BREZTRI, Kerendia | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error